Teva will pay an initial $35 million by the end of 2024, with the remaining amount due by July 1, 2025. Baltimore secured more than three times the funds it would have received from global settlements ...

Christian Olaniran is a digital producer for CBS Baltimore, where he writes stories on diverse topics including politics, arts and culture. With a passion for storytelling and content creation, he ...

It’s the largest settlement New York has reached with a single opioid defendant. Teva Pharmaceuticals agreed Thursday to pay New York $523 million to settle claims stemming from the company’s role in ...

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers, according to ...

The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday. By Sarah Maslin Nir The agency cited Teva’s continuing supply problems as well as those of other drug ...

FILE - An Israeli flag flies outside a Teva Pharmaceutical Industries building on Dec. 14, 2017, in Neot Hovav, Israel. The generic drug maker Teva Pharmaceuticals agreed Monday, Aug. 21, 2023, to pay ...

(NEXSTAR) – Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially carcinogenic chemical that exceeds the “acceptable intake limit.” The ...

Teva Pharmaceuticals will shell out as much as much as $523 million in New York to settle claims that the company contributed to the opioid crisis that has killed nearly half a million Americans, part ...

Teva has been working to address shortfalls at a manufacturing site in California for years, but a recent layoff notice indicates those efforts are winding down. Teva Parenteral Medicines is letting ...